Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:BCRX’

Felix Baker - Baker Bros.

Here is What Hedge Funds Think About BioCryst Pharmaceuticals, Inc. (BCRX)

Hedge funds are known to underperform the bull markets but that’s not because they are bad at investing. Truth be told, most hedge fund managers......(read more)
MILLENNIUM MANAGEMENT

BioCryst Pharmaceuticals, Inc. (BCRX) Are Selling These Hedge Funds

“Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn’t by much. Cumulatively......(read more)

Is BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy?

With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred......(read more)

Here’s What Hedge Funds Think About BioCryst Pharmaceuticals, Inc. (BCRX)

Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into......(read more)

BioCryst Pharmaceuticals, Inc. (BCRX) Hedge Funds Are Snapping Up

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the......(read more)
pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

13D Filing: RA Capital Management and Biocryst Pharmaceuticals Inc (BCRX)

Biocryst Pharmaceuticals Inc (NASDAQ:BCRX): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
Stock Trading, Performance, Stock Analysis

33 Fresh Stories From The World Of Finance Today

1. U.S. Stock Market:   “World stock markets scaled fresh highs on Thursday, with key U.S. indexes lifted by rosy retailer results, while the......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
stocks, analysis, market, numbers, business, ticket, trade, money, price

32 Recent Stories to Keep You Informed About the Financial Markets Today

1. U.S. Stock Market:   “U.S. stock-market benchmark traded firmly higher, with shares of Apple hitting a record, as investors digested a......(read more)
Easiest Md/PhD Programs to Get Into

BioCryst Pharmaceuticals, Inc. (BCRX): A Discount Entry?

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has caught our attention in the biotech space as being a company that has had a bit of a strange start to......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

What Smart Money Thinks about BioCryst Pharmaceuticals, Inc. (BCRX)?

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They......(read more)
David E. Shaw of D.E. Shaw

Biocryst Pharmaceuticals Inc (BCRX): Billionaire David E. Shaw’s Fund Increases Stake

Billionaire David E. Shaw‘s D E Shaw has recently filed a Form 13G with the US SEC in which it reported holding 3.74 million common shares of ......(read more)
Felix Baker - Baker Bros.

Biocryst Pharmaceuticals Inc (BCRX): Baker Bros. Advisors Unloads Nearly 4 Million Shares

Julian Baker and Felix Baker‘s Baker Bros. Advisors recently filed an amended Form 13D with the SEC to report the sale of common shares of Biocryst......(read more)
Small Businesses in High Demand in 2015

Most Popular Healthcare Stocks Under $5

Most securities that cost less than a dinner at a fast-food restaurant are considered to be too risky, with most intra-day traders or other investors......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Biotech-Focused VHCP Management’s Bullish Moves and New Picks

Biotech stocks pop and drop on the smallest whims and whispers, which makes the biotechnology sector one of the most rewarding and volatile sectors out......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Venrock Healthcare Capital Partners Discloses 7.1% Stake in Biocryst Pharmaceuticals Inc (BCRX)

Anders Hove and Bong Koh‘s VHCP Management owns a new position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), as a new filing with the US Securities......(read more)
David E. Shaw of D.E. Shaw

D. E. Shaw & Co Raises Exposure to Biocryst Pharmaceuticals Inc (BCRX)

D. E. Shaw & Co, founded by billionaire David E. Shaw, has reported its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) via a 13G filing......(read more)
Jeff Ubben VALUEACT CAPITAL

Billionaire Ubben Cuts Stake in Adobe (ADBE), Carlson Buys More Archrock (AROC), and 2 Other Moves

There are numerous exceptional money managers who have been able to consistently beat broader market benchmarks, which is just one reason why tracking......(read more)
Nathaniel August - Mangrove Partners

These 4 Stocks Were Just Bought by Baker Bros. Advisors, Clint Carlson, More

The hedge fund industry closed in negative territory for 2015, marking the fourth year of decline for the industry since 1990. Nonetheless, approximately......(read more)
Felix Baker - Baker Bros.

Elite Hedge Funds Making Moves in These Three Stocks

Most investors monitor hedge funds’ 13F filings in order to identify high-potential stocks, and our research has provided evidence that these public......(read more)

Gap Inc, ANI Pharmaceuticals, Ruby Tuesday: Why Are These Stocks Getting Crushed Today?

It’s been a disappointing day for investors of Gap Inc (NYSE:GPS),  BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Ruby Tuesday, Inc. (NYSE:RT......(read more)

RA Capital’s Latest Move In Alcobra Ltd (ADHD) Coming Off Hefty Second Quarter Gains

According to a recent filing with the Securities and Exchange Commission, Peter Kolchinsky‘s RA Capital has initiated a position in Alcobra Ltd (......(read more)
Array Biopharma Inc (NASDAQ:ARRY)

Array Biopharma Inc (ARRY), Vertex Pharmaceuticals Incorporated (VRTX): This Week in Biotech

With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
Alcoa Inc (NYSE:AA)

Earnings Watch News: Alcoa Inc (AA), JPMorgan Chase & Co. (JPM), Wells Fargo & Co (WFC)

Don’t Put Too Much Stock In Alcoa For Earnings Season Insight (Forbes) Alcoa Inc (NYSE:AA) will provide the informal kickoff to first-quarter earnings......(read more)

Hedge Funds Are Selling BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shareholders have witnessed a decrease in hedge fund interest lately. This is interesting, because the stock......(read more)